Celadon Pharmaceuticals has become the first UK-based medical cannabis manufacturer to be granted a Home Office license to sell its products in the UK. 

The London-listed company can now pursue supply deals to sell its cannabis oil to specialized private clinics permitted to prescribe medical marijuana (MMJ). They can also provide MMJ to universities and pharmaceutical companies that are conducting research and development, reported the Financial Times. 

Until now, Celadon was only authorized to cultivate cannabis and manufacture tetrahydrocannabinol (THC) oil under its Home Office license. But on Tuesday, the British Home Office updated Celadon’s license, which enables the company to begin MMJ sales. The move came after the 100,000 sq ft manufacturing facility in Birmingham was granted a Good Manufacturing Practice registration by the UK’s …

Full story available on Benzinga.com